Search
for
Sort by
Research 901–930 of 1000+
- Medical Therapies
- Stem Cell Therapies for Epidermolysis Bullosa Treatment
- Regenerative Therapies for Cosmetic Dermatology for Patients with Diabetes Mellitus: Skin Aging, Aesthetic Concerns, and Evidence-Based Best Practices
- The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
- Hollow polydopamine nanoparticles loading with peptide RL-QN15: a new pro-regenerative therapeutic agent for skin wounds
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- Emerging roles of transit‐amplifying cells in tissue regeneration and cancer
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss
- Dual-drug nanostructured lipid carriers of spironolactone and 2-deoxy-D-ribose for targeted follicular delivery in androgenetic alopecia
- Targeted transferosomal delivery of cetirizine: A new approach to alopecia management
- A Novel 3D Printed Model of Infected Human Hair Follicles to Demonstrate Targeted Delivery of Nanoantibiotics
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Journal for ReAttach Therapy and Developmental Diversities
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Natural Sources of Therapeutic Agents Used in Skin Conditions
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- The therapeutic, diagnostic, and prognostic values of extracellular vesicles (exosomes) in dermatology: A systematic review
- Hydrogels Modulating the Microbiome: Therapies for Tissue Regeneration with Infection Control
- Immune therapies for alopecia areata: evidence and new perspectives
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Targeting Ferroptosis in Sepsis: Therapeutic Potential and Mechanisms of Natural Products and Traditional Chinese Medicine
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability